Wockhardt

Wockhardt to exit its US generics business
- By Ethan Caldwell
- . July 11, 2025
Habil Korakiwala, Chairman, Wockhardt Group | Photo Credit: PAUL NORONHA Drugmaker Wockhardt is realigning its business in the US by focusing on its innovation-driven business,

Tech Query: What Is The Outlook For Samvardhana Motherson International, Arrow Greentech, Wockhardt, Jubilant Foodworks?
- By Ethan Caldwell
- . April 12, 2025
Can I buy Samvardhana Motherson International now for long-term? What is the outlook? Sophia, Kochi Samvardhana Motherson International (₹118.10): The stock is in a downtrend

Wockhardt to exit residual US generics business for “commercial reasons”
- By Ethan Caldwell
- . April 7, 2025
Drugmaker Wockhardt has decided to exit its remaining generics business in the US, for commercial reasons. Over two years ago, the Mumbai-based drugmaker had announced
